About this podcast
The official podcast of the British Journal of Dermatology
Episodes
The newest 20 of 55 episodes
- Episode 55 - Keratinocyte cancer trends in England 2013–2022 · 5 min · Episode 55In this episode of BJD Talks, Sam and Meera discuss the article ‘Trends in keratinocyte cancers in England, 2013–22: basal cell carcinoma incidence, cutaneous squamous cell…
- Episode 54 - Subcutaneous efgartigimod in pemphigus: phase III ADDRESS trial · 4 min · Episode 54In this episode of BJD Talks, Sam and Meera discuss the article ‘Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a…
- Episode 53 - Scaffold delivery of basement membrane motifs for wound healing · 4 min · Episode 53In this episode of BJD Talks, Sam and Meera discuss the article ‘Engineered Caf1 constructs encoding laminin-332 motifs: a novel approach for enhanced cutaneous wound healing’ by…
- Episode 52 - Durability of icotrokinra response through week 52 · 4 min · Episode 52In this episode of BJD Talks, Sam and Meera discuss the article ‘Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the…
- Episode 51 - Skin cancer mortality in Australian and New Zealand kidney transplant recipients · 5 min · Episode 51In this episode of BJD Talks, Sam and Meera discuss the article ‘Skin cancer mortality in Australian and New Zealand kidney transplant recipients: a population-based cohort study…
- Episode 50 - Reducing infant bathing: a randomized controlled feasibility trial · 3 min · Episode 50In this episode of BJD Talks, Sam and Meera discuss the article ‘Randomized controlled feasibility trial of an intervention to reduce infant bathing’ by Perkin et al. The full…
- Episode 49 - Quality of life in patients with BCNS · 4 min · Episode 49In this episode of BJD Talks, Sam and Meera discuss the article ‘Health-related quality of life in patients with basal cell naevus syndrome and high-frequency basal cell…
- Episode 48 - Deucravacitinib in patients with alopecia areata in a phase II trial · 3 min · Episode 48In this episode of BJD Talks, Sam and Meera discuss the article ‘Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata…
- Episode 47 - Serious infection risk with systemic treatments for psoriasis · 4 min · Episode 47In this episode of BJD Talks, Sam and Meera discuss the article ‘Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of…
- Episode 46 - Narrowband vs broadband UVB phototherapy for moderate-to-severe atopic dermatitis · 4 min · Episode 46In this episode of BJD Talks, Sam and Meera discuss the article ‘Narrowband versus broadband ultraviolet B phototherapy for adults with moderate-to-severe atopic dermatitis: a…
- Episode 45 - Inflammation in recessive dystrophic epidermolysis bullosa · 4 min · Episode 45In this episode of BJD Talks, Sam and Meera discuss the article ‘Systemic inflammation in recessive dystrophic epidermolysis bullosa: a 5-year longitudinal study’ by Karakioulaki…
- Episode 44 - Genome-wide meta-analysis in lichen sclerosus · 4 min · Episode 44In this episode of BJD Talks, Sam and Meera discuss the article ‘Genome-wide meta-analysis in lichen sclerosus identifies 14 genomic risk loci’ by Dand et al. The full article…
- Episode 42- Circulating metabolomics profile of psoriasis · 3 min · Episode 42In this episode of BJD Talks, Sam and Meera discuss the article ‘Circulating metabolites associated with psoriasis in the UK Biobank and the HUNT Study: a cross-sectional study…
- Episode 43 - European Photopatch Test Study (POST) · 4 min · Episode 43In this episode of BJD Talks, Sam and Meera discuss the article ‘Prospective multicentre photopatch test study of photoallergy to sunscreens and nonsteroidal anti-inflammatory…
- Episode 41 - Pazopanib for primary cutaneous angiosarcoma · 4 min · Episode 41In this episode of BJD Talks, Sam and Meera discuss the article ‘Efficacy and safety of pazopanib in patients in Japan with primary cutaneous angiosarcoma pretreated with…
- Episode 40 - The Haunting · 3 min · Episode 40In this episode of BJD Talks, Sam and Meera discuss the recently published haiku, ‘The Haunting’ by Krisha Tripathy. The full article can be accessed at…
- Episode 37 - Scoping review of B-cell and antibody responses in human melanoma · 5 min · Episode 37In this episode of BJD Talks, Sam and Meera discuss the article ‘Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human…
- Episode 38 - Non canonical NF-κB signalling in CYLD cutaneous syndrome · 4 min · Episode 38In this episode of BJD Talks, Sam and Meera discuss the article ‘Targeting noncanonical nuclear factor kappa B signalling in CYLD cutaneous syndrome by selective inhibition of…
- Episode 39 - Ethiopia cutaneous leishmaniasis cohort · 4 min · Episode 39In this episode of BJD Talks, Sam and Meera discuss the article ‘Clinical and patient-reported outcomes of cutaneous leishmaniasis treatment in Ethiopia: a prospective…
- Episode 36 - Genomic copy number burden in primary dermal melanoma · 4 min · Episode 36In this episode of BJD Talks, Sam and Meera discuss the article ‘Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanoma’ by Zhao et al…








